MedTrace Logo

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)

NCT01255956 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-01-25

No results posted yet for this study

Summary

The aim of the study is to compare rapamycin eluting stent and paclitaxel eluting balloon catheter in the treatment of restenosis in bare metal stent.

Conditions

  • In-Stent Restenosis

Interventions

DEVICE

Rapamycin eluting stent implantation

Rapamycin eluting stent implantation for in-stent restenosis treatment

DEVICE

Paclitaxel eluting balloon catheter

Paclitaxel eluting balloon catheter for in-stent restenosis treatment

Sponsors & Collaborators

  • KCRI

    collaborator OTHER

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Jacek Legutko, MD, PhD · II Department of Cardiology Medical College Jagiellonian University University Hospital in Krakow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01255956 on ClinicalTrials.gov